CD19-Targeted 19-28z CAR Modified Autologous T Cells Induce High Rates of Complete Remission and Durable Responses in Adult Patients with Relapsed, Refractory B-Cell ALL
暂无分享,去创建一个
M. Sadelain | K. Curran | R. Brentjens | I. Rivière | Xiuyan Wang | Jae H. Park | C. Sauter | M. Davila | Y. Bernal | S. Yoo | E. Halton | Hilda Quintanilla | Terrence Purdon | T. Purdon